Speaker Profiles

Travis Besanger

Travis Besanger

Business & Technical Director - Medical Isotopes


For over a decade Dr. Besanger has built a career in commercialization of radiopharmaceuticals and medical isotope products. Currently, Travis serves as Business & Technical Director - Medical Isotopes at Kinectrics where he Is responsible for building and directing a new commercial medical Isotopes division. In particular Travis Is leading the commercial efforts for Kinectrics to establish large-scale production of Lutetium-177 In partnership with Bruce Power and Framatome.

Before joining Kinectrics Travis held the dual role of Chief Business Officer at the Centre for Probe Development & Commercialization (CPDC) and President of a CPDC subsidiary NuGeneris Specialty Pharmaceuticals. At the CPDC he had accountability for the radiopharmaceutical contract manufacturing (CMO) business unit with responsibility for revenue growth and business strategy. As President of NuGeneris he was responsible for spinning the CMO business out from the CPDC to create a stand-alone company, including securing the required growth and working capital to create an FDA licensed commercial radiotherapy manufacturing facility. Travis also was involved in establishing a Vancouver-based radioisotope company ARTMS that Is focused on the production of Tc-99m and other diagnostic radioisotopes using medical cyclotrons, and he began his career at the Cambridge-based Molecular Insight Pharmaceuticals, a radiopharmaceutical developer that was focused on commercializing targeted radiotherapies for a variety of cancers. Travis received his PhD in Chemistry from McMaster University.

Our Sponsors

Telus Interac Green Shield Canada